Results of intraoperative photodynamic therapy in T1–2 laryngeal cancer
https://doi.org/10.17650/2222-1468-2025-15-3-43-49
Abstract
Introduction. Laryngeal cancer is an important malignancy of the head and neck, with an estimated incidence of 238,000 cases per year. The main risk factors are smoking, human papillomavirus infection, and exposure to occupational carcinogens. Treatment of laryngeal cancer with T1–2 includes surgery and radiation therapy, but both methods have disadvantages: there is a risk of relapse after radiation therapy, and functional impairment after surgery, which necessitates optimization of treatment methods. photodynamic therapy is a promising organ-preserving method based on the targeted destruction of tumor cells by activating the photosensitizer accumulated in them with visible red light.
Materials and methods. The study analyzed the results of combined treatment with intraoperative photodynamic therapy in 74 patients with laryngeal cancer from 2017 to 2023. Inclusion criteria: morphologically confirmed squamous cell carcinoma of the larynx, T1–2 tumor extent and absence of distant metastases. patients were administered photosensitizer (chlorin E6) intravenously 3 hours before surgery. Surgical treatment included endolaryngeal or open laryngeal resections followed by intraoperative photodynamic therapy on the bed of the removed tumor. Oncological and functional results were then assessed for 24 months.
Results. Local recurrence was recorded in 2 (2.7 %) patients in the 1st year and in 3 (4.17 %) patients in the 2nd year. Overall survival was 100 %, larynx preservation was 95.9 %. In the group with a positive resection margin (n = 11), progression was noted in 2 patients. Respiratory, swallowing and vocal functions were restored in all patients. No complications associated with photodynamic therapy were registered.
Conclusion. The high efficiency of a combined approach involving the use of intraoperative photodynamic therapy in early-stage laryngeal cancer has been demonstrated. This method has provided good oncological and functional results. In some cases, it allows you to avoid adjuvant radiation therapy, reduce the risk of complications and shorten the rehabilitation period. further studies of the long-term results of such a combined method will help assess the prospects for its implementation in clinical practice.
About the Authors
P. I. SpirinRussian Federation
4 Koroleva St., Obninsk 249036
К. A. Saidalieva
Russian Federation
1 ter. Studgorodok, Obninsk 249039
F. Е. Sevryukov
Russian Federation
4 Koroleva St., Obninsk 249036
V. N. Kapinus
Russian Federation
4 Koroleva St., Obninsk 249036
V. V. Polkin
Russian Federation
4 Koroleva St., Obninsk 249036
А. D. Kaprin
Russian Federation
4 Koroleva St., Obninsk 249036,
6 Miklukho-Maklaya St., Moscow 117198
3 2nd Botkinsky Proezd, Moscow 125284
S. A. Ivanov
Russian Federation
4 Koroleva St., Obninsk 249036
1 ter. Studgorodok, Obninsk 249039
6 Miklukho-Maklaya St., Moscow 117198
References
1. Radzhabova Z.A., Kotov M.A., Ebert M.A. et al. Advanced laryngeal cancer (literature review). Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2019;18(5):97–107. (In Russ.). DOI: 10.21294/1814-4861-2019-18-5-97-107
2. Divakar P., Davies L. Trends in incidence and mortality of larynx cancer in the US. JAMA Otolaryngol Head Neck Surg 2023;149(1):34–41. DOI: 10.1001/jamaoto.2022.3636
3. Chaturvedi A.K., Engels E.A., Pfeiffer R.M. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. JCO 2011;29(32):4291–301. DOI: 10.1200/JCO.2011.36.4596
4. Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6): 394–424. DOI: 10.3322/caac.21492
5. Malignant neoplasms in Russia in 2024 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2024. (In Russ.).
6. Guimarães A.V., Dedivitis R.A., Matos L.L. et al. Comparison between transoral laser surgery and radiotherapy in the treatment of early glottic cancer: a systematic review and meta-analysis. Sci Rep 2018;8(1):11900. DOI: 10.1038/s41598-018-30218-x
7. Pontes P., Brasil Ode O., Amorim Filho Fde S. et al. Radiotherapy for early glottic cancer and salvage surgery after recurrence. Braz J Otorhinolaryngol 2011;77(3):299–302. DOI: 10.1590/s1808-86942011000300005
8. Kozhanov A.L., Kozhanov L.G., Kravtsov S.A. et al. Modern aspects of organ-preserving surgery for laryngeal cancer. Vestnik otorinolaringologii = Russian Bulletin of Otorhinolaryngology 2022; 87(2):44–50. (In Russ.). DOI: 10.17116/otorino20228702144
9. Graciano A.J., Sonagli M., da Silva A.G. et al. Partial laryngectomy in glottic cancer: complications and oncological results. Braz J Otorhinolaryngol 2016;82(3):275–80. DOI: 10.1016/j.bjorl.2015.05.011
10. Francis D.O., Weymuller E.A. Jr, Parvathaneni U. et al. Dysphagia, stricture, and pneumonia in head and neck cancer patients: does treatment modality matter? Ann Otol Rhinol Laryngol 2010;119(6):391–7. DOI: 10.1177/000348941011900605
11. Goor K.M., Peeters A.J., Mahieu H.F. et al. Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life, and voice quality. Head Neck 2007;29(2):128–36. DOI: 10.1002/hed.20500
12. Campo F., Zocchi J., Ralli M. et al. Laser microsurgery versus radiotherapy versus open partial laryngectomy for T2 laryngeal carcinoma: a systematic review of oncological outcomes. Ear Nose Throat J 2021;100(Suppl 1):51S–58S. DOI: 10.1177/0145561320928198
13. Zamanov M.U., Miroshnichenko N.A., Gorban D.G. et al. Optimization of the postoperative period in patients after emergency tracheostomy surgery. Tavricheskiy mediko-biologicheskiy vestnik = Tavricheskiy Medico-Biological Bulletin 2017;3:209–12. (In Russ.).
14. Bacellar I.O., Tsubone T.M., Pavani C. et al. Photodynamic Efficiency: From molecular photochemistry to cell death. Int J Mol Sci 2015;16(9):20523–59. DOI: 10.3390/ijms160920523
15. Thiruppathi J., Vijayan V., Park I.K. et al. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better. Front Immunol 2024;15:1375767. DOI: 10.3389/fimmu.2024.1375767
16. Schweitzer V.G. PHOTOFRI-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med 2001;29(4):305–13. DOI: 10.1002/lsm.1133
17. Biel M.A. Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol 2007;83(5):1063–8. DOI: 10.1111/j.1751-1097.2007.00153.x
18. Rozhnov V.A., Andreev V.G., Polkin V.V. et al. Vertical resections for larynx cancer with preservation of the thyroid cartridge plates. Vestnik otorinolaringologii = Russian Bulletin of Otorhinolaryngology 2022;87(4):45–50. (In Russ.). DOI: 10.17116/otorino20228704145
Review
For citations:
Spirin P.I., Saidalieva К.A., Sevryukov F.Е., Kapinus V.N., Polkin V.V., Kaprin А.D., Ivanov S.A. Results of intraoperative photodynamic therapy in T1–2 laryngeal cancer. Head and Neck Tumors (HNT). 2025;15(3):43-49. (In Russ.) https://doi.org/10.17650/2222-1468-2025-15-3-43-49

                    
        






























